E
Edythe D. London
Researcher at University of California, Los Angeles
Publications - 492
Citations - 36481
Edythe D. London is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Nicotinic agonist & Methamphetamine. The author has an hindex of 93, co-authored 482 publications receiving 33741 citations. Previous affiliations of Edythe D. London include Icahn School of Medicine at Mount Sinai & Semel Institute for Neuroscience and Human Behavior.
Papers
More filters
Journal ArticleDOI
Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.
TL;DR: The mean effective dose equivalent is estimated to be 0.0278 mSv/MBq (0.103 rem/mCi), indicating that radiation dosimetry associated with 2-[18F]FA is within acceptable limits.
Journal ArticleDOI
No effect of attentional bias modification training in methamphetamine users receiving residential treatment.
Andy C. Dean,Erika L. Nurmi,Scott J. Moeller,Nader Amir,Michelle Rozenman,Dara G. Ghahremani,Maritza Johnson,Robert Berberyan,Gerhard Hellemann,Ziwei Zhang,Edythe D. London +10 more
TL;DR: ABM training did not improve several clinically relevant variables in treatment-seeking methamphetamine users and was not able to influence selection of methamphetamine-related pictures in the Simulated Drug Choice task.
Journal ArticleDOI
Dopamine D3 receptors as a therapeutic target for methamphetamine dependence
TL;DR: Pilot data indicated that buspirone is safe in MA-using individuals and comparison against historical placebo data from this laboratory suggested that at least some aspects of the subjective properties of MA may be diminished during busPirone treatment.
Journal ArticleDOI
Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder
Daniel J. O. Roche,Matthew J. Worley,Kelly E. Courtney,Spencer Bujarski,Edythe D. London,Steven Shoptaw,Lara A. Ray +6 more
TL;DR: The findings indicate that naltrexone moderates the predictive relationship between cue-induced craving and positive subjective effects of MA, thereby suggesting a behavioral mechanism by which nALTrexone may be efficacious in treating MA use disorder.
Journal ArticleDOI
Alexithymia in relation to alcohol expectancies in alcohol-dependent outpatients
Fred Arne Thorberg,Ross McD. Young,Michael Lyvers,Karen A. Sullivan,Penelope Hasking,Edythe D. London,Reidar Tyssen,Jason P. Connor,Jason P. Connor,Gerald F.X. Feeney,Gerald F.X. Feeney +10 more
TL;DR: The findings suggest that alcohol-dependent outpatients with alexithymia may drink to experience intensified negative emotions and improved social functioning.